Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.
about
A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancerThe maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti studyCentral obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational studyDigitalis use and risk of gastrointestinal cancers: A nationwide population-based cohort study.Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis.The Frequency and Risk Factors of Colorectal Adenoma in Health-Check-up Subjects in South Korea: Relationship to Abdominal Obesity and Age.Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.Hormone therapy, DNA methylation and colon cancer.Estrogen and progesterone-related gene variants and colorectal cancer risk in women.Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.The risk of colonic adenomas and colonic cancer in obesityThe proliferating role of insulin and insulin-like growth factors in cancer.A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal womenCirculating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in womenAssociation of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.The aromatase gene (CYP19A1) variants and circulating hepatocyte growth factor in postmenopausal women.Multiple signal pathways in obesity-associated cancer.Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational StudyTesting the proportional hazards assumption in case-cohort analysis.A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.Reproductive history and risk of colorectal cancer in postmenopausal womenA prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.Serum glucose and risk of cancer: a meta-analysis.Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort.Evaluating estradiol levels in male patients with colorectal carcinoma.Type 2 diabetes mellitus and colorectal neoplasia risk in Hispanics: a case-control studyAssociation between plasma adiponectin levels and colorectal cancer risk in womenGenetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women.Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29.Adult BMI Change and Risk of Colon Cancer in Postmenopausal WomenInsulin-like growth factor axis and risk of type 2 diabetes in womenMetabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.Fulvic Acid Attenuates Resistin-Induced Adhesion of HCT-116 Colorectal Cancer Cells to Endothelial Cells
P2860
Q28601163-B71D1313-4E8F-4398-8D16-58C0D532BC60Q28740805-4F130280-24B1-454F-AA00-46664438F97DQ30404178-49807B0D-A995-4DB5-81EE-FF34E3702ABFQ33557595-396C807A-04D6-49E0-A0E3-5E1D86F75F06Q33589372-A409B485-543D-4332-BEF8-7725DA5EACD9Q33701501-78446C82-3392-445F-813F-2B3EBB21B298Q33798566-AD0F09BC-9666-4C44-8C04-438D7CFA8938Q33801418-5CE64981-2346-44E0-A0D3-1EEE569FE41FQ33855690-3A9D8788-A2F0-4CC0-BE6D-5ECBF6CB0DFEQ33862850-D62470BB-0690-4EED-84FB-6C65D47A784FQ33884570-E9111AA7-E572-4CCA-B129-DC012B9F2061Q33917508-50C3C021-9A5E-4A02-A252-48C3C0807822Q34008787-8CDF9437-6A5A-4578-8CBA-E481B196CD25Q34127704-41BBA2F6-7F55-4D78-A1A3-4DE0A1013A90Q34157499-1625CBD1-C50C-4433-83BA-95A8CE0AA5F4Q34172625-8E0B9D36-FB17-4295-9CCB-AFFC925AF5F8Q34236811-6EEF71B9-A25C-42A1-A20C-622C00EF55B1Q34310978-863638CD-3179-4FC7-998D-EE3472ED9436Q34324609-90E74CD8-A690-4E68-9128-3136ABBD6CC8Q34359484-B2BA2382-BCCC-41F6-B70D-7AAEC2AB0666Q34633750-EB1E8539-EED3-48B0-A5A0-A2530EF7AA70Q34662854-94D71381-9B15-44A2-B38F-B9375EF918ABQ34717044-90CD1B39-50FD-495D-859D-ABEF067D9D82Q34802658-0850BEC4-0213-4EE4-B2A1-929F2C40BD12Q34954039-895E32FE-08D2-48AF-B518-65E249D11CFFQ34988342-FC16BC4E-095F-499D-9D1C-EB4AA3F9B0F7Q34988695-2132818B-DAB7-4537-B5FA-1CDCC86C8BCDQ35059999-DC9D64DF-167B-4EF1-8A7C-05C7D3F5F676Q35136036-3E52CE25-DB14-492C-AE39-5B740F90E1F7Q35139544-86F2A169-772D-4040-916E-540E6EC21A8BQ35554717-E165FFE0-8AC9-47D3-85B5-666D0FE3427AQ35738494-90C40A6C-C302-4728-BEF0-7096D6FBE311Q35826255-3BB6CC33-9B11-4353-B8AE-69A6C352AF8AQ36029655-A0BF7174-7F7B-4EBD-8540-1A114E9872E0Q36097117-7E61F4F4-7B7B-4748-915E-330BFDBF2DF4Q36104515-27D1C76E-2423-48C1-8A9E-E2C11BCD2BD0Q36182551-6417E9F1-F380-4A1A-B979-2F56D6453BC6Q36260667-16E27573-0A2E-457B-ADD2-7AB026CAA69EQ36306224-1239BB75-E161-4416-B705-06CFD42FBB73Q36404203-A53B065D-3CDD-4BE5-AC69-206A9DDAB774
P2860
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@ast
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@en
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@nl
type
label
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@ast
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@en
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@nl
prefLabel
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@ast
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@en
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@nl
P2093
P2860
P50
P1433
P1476
Insulin, insulin-like growth f ...... ancer in postmenopausal women.
@en
P2093
Donald R Hoover
Garnet L Anderson
Gloria Y F Ho
Herbert Yu
Howard D Strickler
JoAnn E Manson
Marc J Gunter
Robert C Kaplan
Robert D Burk
P2860
P304
P356
10.1158/0008-5472.CAN-07-2946
P407
P577
2008-01-01T00:00:00Z